VEGFA and choroidal neovascularization: Anti-vascular endothelial growth factor (anti-VEGF) injections have been widely and effectively used for the treatment of neovascular AMD (nvAMD) [2,3], choroidal neovascularization (CNV) of other causes ([4,5] as well as macular edema secondary to diabetes [6,7] or retinal vein occlusion (RVO) [8,9,10].